Your browser doesn't support javascript.
loading
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved.
Anker, Stefan D; Butler, Javed; Usman, Muhammad Shariq; Filippatos, Gerasimos; Ferreira, João Pedro; Bocchi, Edimar; Böhm, Michael; Rocca, Hans Pieter Brunner-La; Choi, Dong-Ju; Chopra, Vijay; Chuquiure, Eduardo; Giannetti, Nadia; Gomez-Mesa, Juan Esteban; Janssens, Stefan; Januzzi, James L; González-Juanatey, José R; Merkely, Bela; Nicholls, Stephen J; Perrone, Sergio V; Piña, Ileana L; Ponikowski, Piotr; Senni, Michele; Sim, David; Spinar, Jindrich; Squire, Iain; Taddei, Stefano; Tsutsui, Hiroyuki; Verma, Subodh; Vinereanu, Dragos; Zhang, Jian; Iwata, Tomoko; Schnee, Janet M; Brueckmann, Martina; Pocock, Stuart J; Zannad, Faiez.
Afiliação
  • Anker SD; Department of Cardiology (CVK) and Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany. s.anker@cachexia.de.
  • Butler J; Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland. s.anker@cachexia.de.
  • Usman MS; Baylor Scott and White Research Institute, Dallas, TX, USA.
  • Filippatos G; University of Mississippi, Jackson, MS, USA.
  • Ferreira JP; University of Mississippi Medical Center, Jackson, MS, USA.
  • Bocchi E; National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Böhm M; Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique 1433, and INSERM U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
  • Rocca HPB; Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal.
  • Choi DJ; Heart Failure Clinics, Instituto do Coracao, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil.
  • Chopra V; Universitätsklinikum des Saarlandes, Homberg/Saar, Germany.
  • Chuquiure E; Maastricht University Medical Center, Maastricht, the Netherlands.
  • Giannetti N; School for Cardiovascular Disease CARIM, Maastricht, the Netherlands.
  • Gomez-Mesa JE; Department of Medicine, Seoul National University Bundang Hospital, Seoul, South Korea.
  • Janssens S; Max Superspeciality Hospital, Saket, New Delhi, India.
  • Januzzi JL; National Institute of Cardiology, Mexico City, Mexico.
  • González-Juanatey JR; McGill University Health Centre, Montreal, Quebec, Canada.
  • Merkely B; Cardiology Service, Fundación Valle del Lili, Universidad Icesi Cali, Cali, Colombia.
  • Nicholls SJ; Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium.
  • Perrone SV; Massachusetts General Hospital and Baim Institute for Clinical Research, Boston, MA, USA.
  • Piña IL; Cardiology Department, University Hospital, CIBERCV, Santiago de Compostela, Spain.
  • Ponikowski P; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Senni M; Victorian Heart Institute, Monash University, Melbourne, Victoria, Australia.
  • Sim D; Argentine Catholic University, Buenos Aires, Argentina.
  • Spinar J; FLENI & IADT Institute, Buenos Aires, Argentina.
  • Squire I; Central Michigan University, Mount Pleasant, MI, USA.
  • Taddei S; Wroclaw Medical University, Wroclaw, Poland.
  • Tsutsui H; Cardiovascular Department, Cardiology Division, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Verma S; National Heart Centre Singapore, Singapore, Singapore.
  • Vinereanu D; Internal Cardiology Department, St Ann University Hospital and Masaryk University Brno, Brno, Czech Republic.
  • Zhang J; NIHR Biomedical Research Centre, University of Leicester, Glenfield Hospital, Leicester, UK.
  • Iwata T; Università di Pisa, Pisa, Italy.
  • Schnee JM; Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Brueckmann M; St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Pocock SJ; University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
  • Zannad F; University and Emergency Hospital, Bucharest, Romania.
Nat Med ; 28(12): 2512-2520, 2022 12.
Article em En | MEDLINE | ID: mdl-36471037
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha